Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Wells Fargo to hold a virtual conference » 04:55
09/10/21
09/10
04:55
09/10/21
04:55
A

Agilent

$177.24 /

-1.54 (-0.86%)

, ABT

Abbott

$127.96 /

-1.11 (-0.86%)

, ARCT

Arcturus Therapeutics

$55.80 /

+0.2 (+0.36%)

, COO

Cooper Companies

$448.62 /

-5.5 (-1.21%)

, EXAS

Exact Sciences

$105.82 /

+2.35 (+2.27%)

, FATE

Fate Therapeutics

$69.31 /

-0.21 (-0.30%)

, FLXN

Flexion

$6.42 /

-0.01 (-0.16%)

, GBT

Global Blood Therapeutics

$30.15 /

+0.14 (+0.47%)

, JNCE

Jounce Therapeutics

$6.61 /

+0.1 (+1.54%)

, JNJ

Johnson & Johnson

$167.94 /

-3.94 (-2.29%)

, KRTX

Karuna Therapeutics

$117.75 /

+0.83 (+0.71%)

, KZR

Kezar Life Sciences

$7.90 /

+0.1 (+1.28%)

, LNTH

Lantheus

$26.17 /

+0.02 (+0.08%)

, MDWD

MediWound

$3.76 /

-0.09 (-2.34%)

, MDT

Medtronic

$133.42 /

-1.715 (-1.27%)

, PACB

Pacific Biosciences

$30.01 /

+0.61 (+2.07%)

, TPTX

Turning Point Therapeutics

$77.37 /

-0.79 (-1.01%)

, SCI

Service Corp.

$62.47 /

-0.99 (-1.56%)

, SMFR

Sema4 Holdings

$8.91 /

+0.23 (+2.65%)

, SGMO

Sangamo

$9.95 /

+0.12 (+1.22%)

, RVNC

Revance

$27.86 /

+0.56 (+2.05%)

, TFX

Teleflex

$385.37 /

-14.73 (-3.68%)

, TECH

Bio-Techne

$507.81 /

+0.92 (+0.18%)

, TSHA

Taysha Gene Therapies

$20.12 /

+0.27 (+1.36%)

, TNDM

TNDM

/

+

, RAPT

Rapt Therapeutics

$36.26 /

+0.2 (+0.55%)

, QURE

uniQure

$35.41 /

+0.73 (+2.10%)

, NVTA

Invitae

$31.73 /

+0.56 (+1.80%)

, ITOS

iTeos Therapeutics

$28.71 /

+0.4 (+1.41%)

, ISRG

Intuitive Surgical

$1,070.49 /

-10.51 (-0.97%)

2021 Wells Fargo…

2021 Wells Fargo Healthcare Virtual Conference to be held on September 9-10.Webcast Link

ShowHide Related Items >><<
TSHA Taysha Gene Therapies
$20.12 /

+0.27 (+1.36%)

TPTX Turning Point Therapeutics
$77.37 /

-0.79 (-1.01%)

TNDM TNDM
/

+

TFX Teleflex
$385.37 /

-14.73 (-3.68%)

TECH Bio-Techne
$507.81 /

+0.92 (+0.18%)

SMFR Sema4 Holdings
$8.91 /

+0.23 (+2.65%)

SGMO Sangamo
$9.95 /

+0.12 (+1.22%)

SCI Service Corp.
$62.47 /

-0.99 (-1.56%)

RVNC Revance
$27.86 /

+0.56 (+2.05%)

RAPT Rapt Therapeutics
$36.26 /

+0.2 (+0.55%)

QURE uniQure
$35.41 /

+0.73 (+2.10%)

PACB Pacific Biosciences
$30.01 /

+0.61 (+2.07%)

NVTA Invitae
$31.73 /

+0.56 (+1.80%)

MDWD MediWound
$3.76 /

-0.09 (-2.34%)

MDT Medtronic
$133.42 /

-1.715 (-1.27%)

LNTH Lantheus
$26.17 /

+0.02 (+0.08%)

KZR Kezar Life Sciences
$7.90 /

+0.1 (+1.28%)

KRTX Karuna Therapeutics
$117.75 /

+0.83 (+0.71%)

JNJ Johnson & Johnson
$167.94 /

-3.94 (-2.29%)

JNCE Jounce Therapeutics
$6.61 /

+0.1 (+1.54%)

ITOS iTeos Therapeutics
$28.71 /

+0.4 (+1.41%)

ISRG Intuitive Surgical
$1,070.49 /

-10.51 (-0.97%)

GBT Global Blood Therapeutics
$30.15 /

+0.14 (+0.47%)

FLXN Flexion
$6.42 /

-0.01 (-0.16%)

FATE Fate Therapeutics
$69.31 /

-0.21 (-0.30%)

EXAS Exact Sciences
$105.82 /

+2.35 (+2.27%)

COO Cooper Companies
$448.62 /

-5.5 (-1.21%)

ARCT Arcturus Therapeutics
$55.80 /

+0.2 (+0.36%)

ABT Abbott
$127.96 /

-1.11 (-0.86%)

A Agilent
$177.24 /

-1.54 (-0.86%)

A Agilent
$177.24 /

-1.54 (-0.86%)

08/18/21 SVB Leerink
Agilent price target raised to $170 from $160 at SVB Leerink
08/18/21 Cowen
Agilent price target raised to $165 from $150 at Cowen
08/18/21 Jefferies
Agilent price target raised to $185 from $155 at Jefferies
08/18/21 KeyBanc
Agilent price target raised to $195 from $160 at KeyBanc
ABT Abbott
$127.96 /

-1.11 (-0.86%)

08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
08/31/21 Barclays
Abbott's Amulet could become 'needle mover,' says Barclays
08/30/21 Piper Sandler
Boston Scientific's Watchman still well positioned, says Piper Sandler
08/23/21 Cowen
Abbott price target raised to $140 from $125 at Cowen
ARCT Arcturus Therapeutics
$55.80 /

+0.2 (+0.36%)

08/25/21 Citi
Arcturus Therapeutics price target lowered to $114 from $118 at Citi
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/12/21 Raymond James
Arcturus Therapeutics downgraded to Underperform from Market Perform at Raymond James
08/12/21 Raymond James
Arcturus Therapeutics downgraded to Underperform from Market Perform at Raymond James
COO Cooper Companies
$448.62 /

-5.5 (-1.21%)

09/03/21 Stifel
Cooper Companies price target raised to $475 from $450 at Stifel
09/03/21 Citi
Cooper Companies price target raised to $453 from $400 at Citi
09/03/21 Oppenheimer
Cooper Companies price target raised to $475 from $405 at Oppenheimer
09/03/21 KeyBanc
Cooper Companies price target raised to $476 from $444 at KeyBanc
EXAS Exact Sciences
$105.82 /

+2.35 (+2.27%)

09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
08/03/21 Evercore ISI
Exact Sciences weakness 'exaggerated' after CFO's 10b5 sale, says Evercore ISI
07/29/21 Canaccord
Exact Sciences price target lowered to $160 from $185 at Canaccord
07/29/21 Oppenheimer
Exact Sciences price target lowered to $155 from $161 at Oppenheimer
FATE Fate Therapeutics
$69.31 /

-0.21 (-0.30%)

08/26/21
Fly Intel: Top five analyst initiations
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/20/21 Piper Sandler
Fate Therapeutics selloff on data a buying opportunity, says Piper Sandler
FLXN Flexion
$6.42 /

-0.01 (-0.16%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
GBT Global Blood Therapeutics
$30.15 /

+0.14 (+0.47%)

08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Piper Sandler
Global Blood price target lowered to $40 from $45 at Piper Sandler
JNCE Jounce Therapeutics
$6.61 /

+0.1 (+1.54%)

08/05/21 Piper Sandler
Jounce Therapeutics price target lowered to $17 from $20 at Piper Sandler
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
JNJ Johnson & Johnson
$167.94 /

-3.94 (-2.29%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades J&J to Equal Weight amid limited mid-term newsflow
09/07/21 Morgan Stanley
Johnson & Johnson downgraded to Equal Weight from Overweight at Morgan Stanley
KRTX Karuna Therapeutics
$117.75 /

+0.83 (+0.71%)

08/30/21 Citi
Karuna Therapeutics initiated with a Buy at Citi
07/28/21
Fly Intel: Top five analyst initiations
07/28/21 Jefferies
Karuna Therapeutics initiated with a Buy at Jefferies
06/30/21 Citi
Karuna Therapeutics selloff brings buying opportunity, says Citi
KZR Kezar Life Sciences
$7.90 /

+0.1 (+1.28%)

07/20/21 JonesTrading
Kezar Life Sciences initiated with a Buy at JonesTrading
07/20/21 JonesTrading
Kezar Life Sciences initiated with a Buy at JonesTrading
LNTH Lantheus
$26.17 /

+0.02 (+0.08%)

02/01/21
Fly Intel: Top five analyst initiations
02/01/21 SVB Leerink
SVB Leerink bullish on Lantheus, initiates with an Outperform
02/01/21 SVB Leerink
Lantheus initiated with an Outperform at SVB Leerink
12/29/20 Credit Suisse
Lantheus price target lowered to $14 from $16 at Credit Suisse
MDWD MediWound
$3.76 /

-0.09 (-2.34%)

06/29/21 Oppenheimer
MediWound NexoBrid CRL as expected, says Oppenheimer
03/02/21 Aegis
MediWound initiated with a Buy at Aegis
02/26/21 H.C. Wainwright
MediWound price target raised to $7 from $5.50 at H.C. Wainwright
10/19/20 BTIG
Vericel price target raised to $30 from $23 at BTIG
MDT Medtronic
$133.42 /

-1.715 (-1.27%)

08/27/21 Argus
Medtronic price target raised to $165 from $150 at Argus
08/25/21 Truist
Medtronic price target raised to $148 from $138 at Truist
08/25/21 Credit Suisse
Medtronic price target raised to $146 from $137 at Credit Suisse
08/25/21 Wells Fargo
Medtronic price target raised to $151 from $140 at Wells Fargo
PACB Pacific Biosciences
$30.01 /

+0.61 (+2.07%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
TPTX Turning Point Therapeutics
$77.37 /

-0.79 (-1.01%)

05/06/21 Roth Capital
Turning Point 'significantly undervalued' with catalysts ahead, says Roth
04/13/21 Roth Capital
Turning Point combo data show 'expansive pipeline potential,' says Roth Capital
04/06/21 Roth Capital
Turning Point price target raised to $175 from $170 at Roth Capital
03/02/21 Roth Capital
Turning Point has 'many value-driving catalysts' in 2021, says Roth Capital
SCI Service Corp.
$62.47 /

-0.99 (-1.56%)

05/10/21 Oppenheimer
Service Corp. price target raised to $59 from $54 at Oppenheimer
11/02/20 Credit Suisse
Service Corp. price target raised to $55 from $50 at Credit Suisse
SMFR Sema4 Holdings
$8.91 /

+0.23 (+2.65%)

SGMO Sangamo
$9.95 /

+0.12 (+1.22%)

05/03/21 RBC Capital
Sangamo initiated with an Outperform at RBC Capital
03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
RVNC Revance
$27.86 /

+0.56 (+2.05%)

05/11/21 Mizuho
Revance price target lowered to $36 from $37 at Mizuho
04/23/21 Mizuho
Revance price target raised to $37 from $33 at Mizuho
02/23/21 Mizuho
Revance price target raised to $33 from $30 at Mizuho
02/23/21 H.C. Wainwright
Revance price target raised to $35 from $33 at H.C. Wainwright
TFX Teleflex
$385.37 /

-14.73 (-3.68%)

09/07/21 Raymond James
Teleflex assumed with an Outperform at Raymond James
08/02/21 KeyBanc
Teleflex price target lowered to $439 from $448 at KeyBanc
07/19/21 SVB Leerink
Teleflex downgraded to Market Perform from Outperform at SVB Leerink
07/15/21 Piper Sandler
Teleflex, Itamar pullbacks on proposed rate cuts overdone, says Piper Sandler
TECH Bio-Techne
$507.81 /

+0.92 (+0.18%)

08/24/21 Argus
Bio-Techne price target raised to $540 from $490 at Argus
08/06/21 Baird
Bio-Techne price target raised to $522 from $430 at Baird
08/05/21 Benchmark
Bio-Techne price target raised to $540 from $480 at Benchmark
06/18/21 Argus
Bio-Techne price target raised to $490 from $440 at Argus
TSHA Taysha Gene Therapies
$20.12 /

+0.27 (+1.36%)

08/17/21 Chardan
Taysha Gene Therapies price target lowered to $60 from $67.50 at Chardan
07/15/21 Needham
Taysha Gene Therapies initiated with a Buy at Needham
07/09/21 Chardan
Taysha Gene Therapies coverage transferred at Chardan
06/24/21 Truist
Truist starts Taysha Gene Therapies at Buy on potential de-risking events
TNDM TNDM
/

+

08/05/21 SVB Leerink
Tandem Diabetes price target raised to $123 from $102 at SVB Leerink
08/05/21 Craig-Hallum
Tandem Diabetes price target raised to $153 from $140 at Craig-Hallum
08/05/21 Wells Fargo
Tandem Diabetes price target raised to $121 from $112 at Wells Fargo
08/05/21 Oppenheimer
Tandem Diabetes price target raised to $140 from $135 at Oppenheimer
RAPT Rapt Therapeutics
$36.26 /

+0.2 (+0.55%)

08/12/21 SVB Leerink
Rapt Therapeutics initiated with an Outperform at SVB Leerink
07/12/21 Roth Capital
Roth adds more 'SMID-cap' names to second half top picks
06/23/21 JMP Securities
JMP raises Evelo Biosciences price target to $38 after Rapt reports data
06/23/21 H.C. Wainwright
Rapt Therapeutics price target raised to $56 from $29 at H.C. Wainwright
QURE uniQure
$35.41 /

+0.73 (+2.10%)

07/27/21 Chardan
uniQure price target lowered to $95 from $100 at Chardan
07/09/21 Chardan
uniQure coverage transferred at Chardan
06/23/21 Chardan
uniQure filing delay could yield better label for EtranaDez, says Chardan
06/16/21 Chardan
uniQure on track for 'powerful' Huntington's catalyst, says Chardan
NVTA Invitae
$31.73 /

+0.56 (+1.80%)

08/04/21 Benchmark
Invitae upgraded to Buy from Hold at Benchmark
06/21/21 Wells Fargo
Invitae price target raised to $35 from $30 at Wells Fargo
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
ITOS iTeos Therapeutics
$28.71 /

+0.4 (+1.41%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
ISRG Intuitive Surgical
$1,070.49 /

-10.51 (-0.97%)

07/22/21 Deutsche Bank
Intuitive Surgical price target raised to $925 from $825 at Deutsche Bank
07/21/21 SVB Leerink
Intuitive Surgical price target raised to $975 from $930 at SVB Leerink
07/21/21 Evercore ISI
Intuitive Surgical price target raised to $980 from $825 at Evercore ISI
07/21/21 Wells Fargo
Intuitive Surgical price target raised to $1,060 from $916 at Wells Fargo
TSHA Taysha Gene Therapies
$20.12 /

+0.27 (+1.36%)

TPTX Turning Point Therapeutics
$77.37 /

-0.79 (-1.01%)

TNDM TNDM
/

+

TFX Teleflex
$385.37 /

-14.73 (-3.68%)

SGMO Sangamo
$9.95 /

+0.12 (+1.22%)

SCI Service Corp.
$62.47 /

-0.99 (-1.56%)

RVNC Revance
$27.86 /

+0.56 (+2.05%)

RAPT Rapt Therapeutics
$36.26 /

+0.2 (+0.55%)

QURE uniQure
$35.41 /

+0.73 (+2.10%)

PACB Pacific Biosciences
$30.01 /

+0.61 (+2.07%)

NVTA Invitae
$31.73 /

+0.56 (+1.80%)

MDWD MediWound
$3.76 /

-0.09 (-2.34%)

MDT Medtronic
$133.42 /

-1.715 (-1.27%)

LNTH Lantheus
$26.17 /

+0.02 (+0.08%)

KZR Kezar Life Sciences
$7.90 /

+0.1 (+1.28%)

KRTX Karuna Therapeutics
$117.75 /

+0.83 (+0.71%)

JNJ Johnson & Johnson
$167.94 /

-3.94 (-2.29%)

JNCE Jounce Therapeutics
$6.61 /

+0.1 (+1.54%)

ITOS iTeos Therapeutics
$28.71 /

+0.4 (+1.41%)

ISRG Intuitive Surgical
$1,070.49 /

-10.51 (-0.97%)

GBT Global Blood Therapeutics
$30.15 /

+0.14 (+0.47%)

FLXN Flexion
$6.42 /

-0.01 (-0.16%)

FATE Fate Therapeutics
$69.31 /

-0.21 (-0.30%)

EXAS Exact Sciences
$105.82 /

+2.35 (+2.27%)

COO Cooper Companies
$448.62 /

-5.5 (-1.21%)

ARCT Arcturus Therapeutics
$55.80 /

+0.2 (+0.36%)

ABT Abbott
$127.96 /

-1.11 (-0.86%)

A Agilent
$177.24 /

-1.54 (-0.86%)

  • 16
    Jun
  • 10
    Mar
  • 02
    Mar
  • 22
    Jan
  • 06
    Jan
  • 08
    Dec
  • 11
    Nov
  • 27
    Oct
  • 24
    Sep
NVTA Invitae
$31.73 /

+0.56 (+1.80%)

MDT Medtronic
$133.42 /

-1.715 (-1.27%)

JNJ Johnson & Johnson
$167.94 /

-3.94 (-2.29%)

ITOS iTeos Therapeutics
$28.71 /

+0.4 (+1.41%)

ISRG Intuitive Surgical
$1,070.49 /

-10.51 (-0.97%)

EXAS Exact Sciences
$105.82 /

+2.35 (+2.27%)

ABT Abbott
$127.96 /

-1.11 (-0.86%)

TSHA Taysha Gene Therapies
$20.12 /

+0.27 (+1.36%)

TPTX Turning Point Therapeutics
$77.37 /

-0.79 (-1.01%)

RAPT Rapt Therapeutics
$36.26 /

+0.2 (+0.55%)

QURE uniQure
$35.41 /

+0.73 (+2.10%)

MDWD MediWound
$3.76 /

-0.09 (-2.34%)

MDT Medtronic
$133.42 /

-1.715 (-1.27%)

LNTH Lantheus
$26.17 /

+0.02 (+0.08%)

JNJ Johnson & Johnson
$167.94 /

-3.94 (-2.29%)

ITOS iTeos Therapeutics
$28.71 /

+0.4 (+1.41%)

ISRG Intuitive Surgical
$1,070.49 /

-10.51 (-0.97%)

GBT Global Blood Therapeutics
$30.15 /

+0.14 (+0.47%)

FLXN Flexion
$6.42 /

-0.01 (-0.16%)

FATE Fate Therapeutics
$69.31 /

-0.21 (-0.30%)

EXAS Exact Sciences
$105.82 /

+2.35 (+2.27%)

ARCT Arcturus Therapeutics
$55.80 /

+0.2 (+0.36%)

ABT Abbott
$127.96 /

-1.11 (-0.86%)

A Agilent
$177.24 /

-1.54 (-0.86%)

SMFR Sema4 Holdings
$8.91 /

+0.23 (+2.65%)

RAPT Rapt Therapeutics
$36.26 /

+0.2 (+0.55%)

PACB Pacific Biosciences
$30.01 /

+0.61 (+2.07%)

NVTA Invitae
$31.73 /

+0.56 (+1.80%)

MDWD MediWound
$3.76 /

-0.09 (-2.34%)

MDT Medtronic
$133.42 /

-1.715 (-1.27%)

JNJ Johnson & Johnson
$167.94 /

-3.94 (-2.29%)

ITOS iTeos Therapeutics
$28.71 /

+0.4 (+1.41%)

ISRG Intuitive Surgical
$1,070.49 /

-10.51 (-0.97%)

COO Cooper Companies
$448.62 /

-5.5 (-1.21%)

ABT Abbott
$127.96 /

-1.11 (-0.86%)

A Agilent
$177.24 /

-1.54 (-0.86%)

Conference/Events
Wells Fargo to hold a virtual conference » 04:55
09/09/21
09/09
04:55
09/09/21
04:55
A

Agilent

$178.68 /

+0.93 (+0.52%)

, ABT

Abbott

$129.07 /

+0.7 (+0.55%)

, ARCT

Arcturus Therapeutics

$55.52 /

-1.03 (-1.82%)

, COO

Cooper Companies

$454.12 /

+6.85 (+1.53%)

, EXAS

Exact Sciences

$103.47 /

-1.52 (-1.45%)

, FATE

Fate Therapeutics

$69.52 /

-3.57 (-4.88%)

, FLXN

Flexion

$6.44 /

+0.165 (+2.63%)

, GBT

Global Blood Therapeutics

$30.01 /

+0.23 (+0.77%)

, JNCE

Jounce Therapeutics

$6.51 /

+0.015 (+0.23%)

, JNJ

Johnson & Johnson

$171.88 /

-0.41 (-0.24%)

, KRTX

Karuna Therapeutics

$116.74 /

-4.93 (-4.05%)

, KZR

Kezar Life Sciences

$7.79 /

-0.03 (-0.38%)

, LNTH

Lantheus

$26.17 /

+0.06 (+0.23%)

, MDWD

MediWound

$3.85 /

-0.07 (-1.79%)

, MDT

Medtronic

$135.13 /

+0.57 (+0.42%)

, PACB

Pacific Biosciences

$29.40 /

-0.9 (-2.97%)

, TPTX

Turning Point Therapeutics

$78.16 /

-1.32 (-1.66%)

, SCI

Service Corp.

$63.46 /

+0.825 (+1.32%)

, SMFR

Sema4 Holdings

$8.68 /

-0.55 (-5.96%)

, SGMO

Sangamo

$9.83 /

-0.19 (-1.90%)

, RVNC

Revance

$27.35 /

+0.06 (+0.22%)

, TFX

Teleflex

$400.07 /

+1.03 (+0.26%)

, TECH

Bio-Techne

$507.70 /

-6.81 (-1.32%)

, TSHA

Taysha Gene Therapies

$19.76 /

-1.81 (-8.39%)

, TNDM

TNDM

/

+

, RAPT

Rapt Therapeutics

$36.06 /

-0.14 (-0.39%)

, QURE

uniQure

$34.68 /

-0.24 (-0.69%)

, NVTA

Invitae

$31.17 /

-0.545 (-1.72%)

, ITOS

iTeos Therapeutics

$28.26 /

-0.88 (-3.02%)

, ISRG

Intuitive Surgical

$1,082.15 /

+4.97 (+0.46%)

2021 Wells Fargo…

2021 Wells Fargo Healthcare Virtual Conference to be held on September 9-10.Webcast Link

ShowHide Related Items >><<
TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

TNDM TNDM
/

+

TFX Teleflex
$400.07 /

+1.03 (+0.26%)

TECH Bio-Techne
$507.70 /

-6.81 (-1.32%)

SMFR Sema4 Holdings
$8.68 /

-0.55 (-5.96%)

SGMO Sangamo
$9.83 /

-0.19 (-1.90%)

SCI Service Corp.
$63.46 /

+0.825 (+1.32%)

RVNC Revance
$27.35 /

+0.06 (+0.22%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

KZR Kezar Life Sciences
$7.79 /

-0.03 (-0.38%)

KRTX Karuna Therapeutics
$116.74 /

-4.93 (-4.05%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

FLXN Flexion
$6.44 /

+0.165 (+2.63%)

FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

A Agilent
$178.68 /

+0.93 (+0.52%)

08/18/21 SVB Leerink
Agilent price target raised to $170 from $160 at SVB Leerink
08/18/21 Cowen
Agilent price target raised to $165 from $150 at Cowen
08/18/21 Jefferies
Agilent price target raised to $185 from $155 at Jefferies
08/18/21 KeyBanc
Agilent price target raised to $195 from $160 at KeyBanc
ABT Abbott
$129.07 /

+0.7 (+0.55%)

08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
08/31/21 Barclays
Abbott's Amulet could become 'needle mover,' says Barclays
08/30/21 Piper Sandler
Boston Scientific's Watchman still well positioned, says Piper Sandler
08/23/21 Cowen
Abbott price target raised to $140 from $125 at Cowen
ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

08/25/21 Citi
Arcturus Therapeutics price target lowered to $114 from $118 at Citi
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/12/21 Raymond James
Arcturus Therapeutics downgraded to Underperform from Market Perform at Raymond James
08/12/21 Raymond James
Arcturus Therapeutics downgraded to Underperform from Market Perform at Raymond James
COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

09/03/21 Stifel
Cooper Companies price target raised to $475 from $450 at Stifel
09/03/21 Citi
Cooper Companies price target raised to $453 from $400 at Citi
09/03/21 Oppenheimer
Cooper Companies price target raised to $475 from $405 at Oppenheimer
09/03/21 KeyBanc
Cooper Companies price target raised to $476 from $444 at KeyBanc
EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
08/03/21 Evercore ISI
Exact Sciences weakness 'exaggerated' after CFO's 10b5 sale, says Evercore ISI
07/29/21 Canaccord
Exact Sciences price target lowered to $160 from $185 at Canaccord
07/29/21 Oppenheimer
Exact Sciences price target lowered to $155 from $161 at Oppenheimer
FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

08/26/21
Fly Intel: Top five analyst initiations
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/20/21 Piper Sandler
Fate Therapeutics selloff on data a buying opportunity, says Piper Sandler
FLXN Flexion
$6.44 /

+0.165 (+2.63%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Piper Sandler
Global Blood price target lowered to $40 from $45 at Piper Sandler
JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

08/05/21 Piper Sandler
Jounce Therapeutics price target lowered to $17 from $20 at Piper Sandler
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades J&J to Equal Weight amid limited mid-term newsflow
09/07/21 Morgan Stanley
Johnson & Johnson downgraded to Equal Weight from Overweight at Morgan Stanley
08/20/21 Morgan Stanley
J&J CEO change 'a surprise,' but not due to business issues, says Morgan Stanley
KRTX Karuna Therapeutics
$116.74 /

-4.93 (-4.05%)

08/30/21 Citi
Karuna Therapeutics initiated with a Buy at Citi
07/28/21
Fly Intel: Top five analyst initiations
07/28/21 Jefferies
Karuna Therapeutics initiated with a Buy at Jefferies
06/30/21 Citi
Karuna Therapeutics selloff brings buying opportunity, says Citi
KZR Kezar Life Sciences
$7.79 /

-0.03 (-0.38%)

07/20/21 JonesTrading
Kezar Life Sciences initiated with a Buy at JonesTrading
07/20/21 JonesTrading
Kezar Life Sciences initiated with a Buy at JonesTrading
LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

02/01/21
Fly Intel: Top five analyst initiations
02/01/21 SVB Leerink
SVB Leerink bullish on Lantheus, initiates with an Outperform
02/01/21 SVB Leerink
Lantheus initiated with an Outperform at SVB Leerink
12/29/20 Credit Suisse
Lantheus price target lowered to $14 from $16 at Credit Suisse
MDWD MediWound
$3.85 /

-0.07 (-1.79%)

06/29/21 Oppenheimer
MediWound NexoBrid CRL as expected, says Oppenheimer
03/02/21 Aegis
MediWound initiated with a Buy at Aegis
02/26/21 H.C. Wainwright
MediWound price target raised to $7 from $5.50 at H.C. Wainwright
10/19/20 BTIG
Vericel price target raised to $30 from $23 at BTIG
MDT Medtronic
$135.13 /

+0.57 (+0.42%)

08/27/21 Argus
Medtronic price target raised to $165 from $150 at Argus
08/25/21 Truist
Medtronic price target raised to $148 from $138 at Truist
08/25/21 Credit Suisse
Medtronic price target raised to $146 from $137 at Credit Suisse
08/25/21 Wells Fargo
Medtronic price target raised to $151 from $140 at Wells Fargo
PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

05/06/21 Roth Capital
Turning Point 'significantly undervalued' with catalysts ahead, says Roth
04/13/21 Roth Capital
Turning Point combo data show 'expansive pipeline potential,' says Roth Capital
04/06/21 Roth Capital
Turning Point price target raised to $175 from $170 at Roth Capital
03/02/21 Roth Capital
Turning Point has 'many value-driving catalysts' in 2021, says Roth Capital
SCI Service Corp.
$63.46 /

+0.825 (+1.32%)

05/10/21 Oppenheimer
Service Corp. price target raised to $59 from $54 at Oppenheimer
11/02/20 Credit Suisse
Service Corp. price target raised to $55 from $50 at Credit Suisse
SMFR Sema4 Holdings
$8.68 /

-0.55 (-5.96%)

SGMO Sangamo
$9.83 /

-0.19 (-1.90%)

05/03/21 RBC Capital
Sangamo initiated with an Outperform at RBC Capital
03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
RVNC Revance
$27.35 /

+0.06 (+0.22%)

05/11/21 Mizuho
Revance price target lowered to $36 from $37 at Mizuho
04/23/21 Mizuho
Revance price target raised to $37 from $33 at Mizuho
02/23/21 Mizuho
Revance price target raised to $33 from $30 at Mizuho
02/23/21 H.C. Wainwright
Revance price target raised to $35 from $33 at H.C. Wainwright
TFX Teleflex
$400.07 /

+1.03 (+0.26%)

09/07/21 Raymond James
Teleflex assumed with an Outperform at Raymond James
08/02/21 KeyBanc
Teleflex price target lowered to $439 from $448 at KeyBanc
07/19/21 SVB Leerink
Teleflex downgraded to Market Perform from Outperform at SVB Leerink
07/15/21 Piper Sandler
Teleflex, Itamar pullbacks on proposed rate cuts overdone, says Piper Sandler
TECH Bio-Techne
$507.70 /

-6.81 (-1.32%)

08/24/21 Argus
Bio-Techne price target raised to $540 from $490 at Argus
08/06/21 Baird
Bio-Techne price target raised to $522 from $430 at Baird
08/05/21 Benchmark
Bio-Techne price target raised to $540 from $480 at Benchmark
06/18/21 Argus
Bio-Techne price target raised to $490 from $440 at Argus
TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

08/17/21 Chardan
Taysha Gene Therapies price target lowered to $60 from $67.50 at Chardan
07/15/21 Needham
Taysha Gene Therapies initiated with a Buy at Needham
07/09/21 Chardan
Taysha Gene Therapies coverage transferred at Chardan
06/24/21 Truist
Truist starts Taysha Gene Therapies at Buy on potential de-risking events
TNDM TNDM
/

+

08/05/21 SVB Leerink
Tandem Diabetes price target raised to $123 from $102 at SVB Leerink
08/05/21 Craig-Hallum
Tandem Diabetes price target raised to $153 from $140 at Craig-Hallum
08/05/21 Wells Fargo
Tandem Diabetes price target raised to $121 from $112 at Wells Fargo
08/05/21 Oppenheimer
Tandem Diabetes price target raised to $140 from $135 at Oppenheimer
RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

08/12/21 SVB Leerink
Rapt Therapeutics initiated with an Outperform at SVB Leerink
07/12/21 Roth Capital
Roth adds more 'SMID-cap' names to second half top picks
06/23/21 JMP Securities
JMP raises Evelo Biosciences price target to $38 after Rapt reports data
06/23/21 H.C. Wainwright
Rapt Therapeutics price target raised to $56 from $29 at H.C. Wainwright
QURE uniQure
$34.68 /

-0.24 (-0.69%)

07/27/21 Chardan
uniQure price target lowered to $95 from $100 at Chardan
07/09/21 Chardan
uniQure coverage transferred at Chardan
06/23/21 Chardan
uniQure filing delay could yield better label for EtranaDez, says Chardan
06/16/21 Chardan
uniQure on track for 'powerful' Huntington's catalyst, says Chardan
NVTA Invitae
$31.17 /

-0.545 (-1.72%)

08/04/21 Benchmark
Invitae upgraded to Buy from Hold at Benchmark
06/21/21 Wells Fargo
Invitae price target raised to $35 from $30 at Wells Fargo
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

07/22/21 Deutsche Bank
Intuitive Surgical price target raised to $925 from $825 at Deutsche Bank
07/21/21 SVB Leerink
Intuitive Surgical price target raised to $975 from $930 at SVB Leerink
07/21/21 Evercore ISI
Intuitive Surgical price target raised to $980 from $825 at Evercore ISI
07/21/21 Wells Fargo
Intuitive Surgical price target raised to $1,060 from $916 at Wells Fargo
TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

TNDM TNDM
/

+

TFX Teleflex
$400.07 /

+1.03 (+0.26%)

SGMO Sangamo
$9.83 /

-0.19 (-1.90%)

SCI Service Corp.
$63.46 /

+0.825 (+1.32%)

RVNC Revance
$27.35 /

+0.06 (+0.22%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

KZR Kezar Life Sciences
$7.79 /

-0.03 (-0.38%)

KRTX Karuna Therapeutics
$116.74 /

-4.93 (-4.05%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

FLXN Flexion
$6.44 /

+0.165 (+2.63%)

FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

  • 16
    Jun
  • 10
    Mar
  • 02
    Mar
  • 22
    Jan
  • 06
    Jan
  • 08
    Dec
  • 11
    Nov
  • 27
    Oct
  • 24
    Sep
NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

FLXN Flexion
$6.44 /

+0.165 (+2.63%)

FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

SMFR Sema4 Holdings
$8.68 /

-0.55 (-5.96%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

Conference/Events
Wells Fargo to hold a virtual conference » 17:31
09/08/21
09/08
17:31
09/08/21
17:31
A

Agilent

$178.68 /

+0.93 (+0.52%)

, ABT

Abbott

$129.07 /

+0.7 (+0.55%)

, ARCT

Arcturus Therapeutics

$55.52 /

-1.03 (-1.82%)

, COO

Cooper Companies

$454.12 /

+6.85 (+1.53%)

, EXAS

Exact Sciences

$103.47 /

-1.52 (-1.45%)

, FATE

Fate Therapeutics

$69.52 /

-3.57 (-4.88%)

, FLXN

Flexion

$6.44 /

+0.165 (+2.63%)

, GBT

Global Blood Therapeutics

$30.01 /

+0.23 (+0.77%)

, JNCE

Jounce Therapeutics

$6.51 /

+0.015 (+0.23%)

, JNJ

Johnson & Johnson

$171.88 /

-0.41 (-0.24%)

, KRTX

Karuna Therapeutics

$116.74 /

-4.93 (-4.05%)

, KZR

Kezar Life Sciences

$7.79 /

-0.03 (-0.38%)

, LNTH

Lantheus

$26.17 /

+0.06 (+0.23%)

, MDWD

MediWound

$3.85 /

-0.07 (-1.79%)

, MDT

Medtronic

$135.13 /

+0.57 (+0.42%)

, PACB

Pacific Biosciences

$29.40 /

-0.9 (-2.97%)

, TPTX

Turning Point Therapeutics

$78.16 /

-1.32 (-1.66%)

, SCI

Service Corp.

$63.46 /

+0.825 (+1.32%)

, SMFR

Sema4 Holdings

$8.68 /

-0.55 (-5.96%)

, SGMO

Sangamo

$9.83 /

-0.19 (-1.90%)

, RVNC

Revance

$27.35 /

+0.06 (+0.22%)

, TFX

Teleflex

$400.07 /

+1.03 (+0.26%)

, TECH

Bio-Techne

$507.70 /

-6.81 (-1.32%)

, TSHA

Taysha Gene Therapies

$19.76 /

-1.81 (-8.39%)

, TNDM

TNDM

/

+

, RAPT

Rapt Therapeutics

$36.06 /

-0.14 (-0.39%)

, QURE

uniQure

$34.68 /

-0.24 (-0.69%)

, NVTA

Invitae

$31.17 /

-0.545 (-1.72%)

, ITOS

iTeos Therapeutics

$28.26 /

-0.88 (-3.02%)

, ISRG

Intuitive Surgical

$1,082.15 /

+4.97 (+0.46%)

2021 Wells Fargo…

2021 Wells Fargo Healthcare Virtual Conference to be held on September 9-10.Webcast Link

ShowHide Related Items >><<
TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

TNDM TNDM
/

+

TFX Teleflex
$400.07 /

+1.03 (+0.26%)

TECH Bio-Techne
$507.70 /

-6.81 (-1.32%)

SMFR Sema4 Holdings
$8.68 /

-0.55 (-5.96%)

SGMO Sangamo
$9.83 /

-0.19 (-1.90%)

SCI Service Corp.
$63.46 /

+0.825 (+1.32%)

RVNC Revance
$27.35 /

+0.06 (+0.22%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

KZR Kezar Life Sciences
$7.79 /

-0.03 (-0.38%)

KRTX Karuna Therapeutics
$116.74 /

-4.93 (-4.05%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

FLXN Flexion
$6.44 /

+0.165 (+2.63%)

FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

A Agilent
$178.68 /

+0.93 (+0.52%)

08/18/21 SVB Leerink
Agilent price target raised to $170 from $160 at SVB Leerink
08/18/21 Cowen
Agilent price target raised to $165 from $150 at Cowen
08/18/21 Jefferies
Agilent price target raised to $185 from $155 at Jefferies
08/18/21 KeyBanc
Agilent price target raised to $195 from $160 at KeyBanc
ABT Abbott
$129.07 /

+0.7 (+0.55%)

08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
08/31/21 Barclays
Abbott's Amulet could become 'needle mover,' says Barclays
08/30/21 Piper Sandler
Boston Scientific's Watchman still well positioned, says Piper Sandler
08/23/21 Cowen
Abbott price target raised to $140 from $125 at Cowen
ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

08/25/21 Citi
Arcturus Therapeutics price target lowered to $114 from $118 at Citi
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/12/21 Raymond James
Arcturus Therapeutics downgraded to Underperform from Market Perform at Raymond James
08/12/21 Raymond James
Arcturus Therapeutics downgraded to Underperform from Market Perform at Raymond James
COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

09/03/21 Stifel
Cooper Companies price target raised to $475 from $450 at Stifel
09/03/21 Citi
Cooper Companies price target raised to $453 from $400 at Citi
09/03/21 Oppenheimer
Cooper Companies price target raised to $475 from $405 at Oppenheimer
09/03/21 KeyBanc
Cooper Companies price target raised to $476 from $444 at KeyBanc
EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
08/03/21 Evercore ISI
Exact Sciences weakness 'exaggerated' after CFO's 10b5 sale, says Evercore ISI
07/29/21 Canaccord
Exact Sciences price target lowered to $160 from $185 at Canaccord
07/29/21 Oppenheimer
Exact Sciences price target lowered to $155 from $161 at Oppenheimer
FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

08/26/21
Fly Intel: Top five analyst initiations
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/20/21 Piper Sandler
Fate Therapeutics selloff on data a buying opportunity, says Piper Sandler
FLXN Flexion
$6.44 /

+0.165 (+2.63%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Piper Sandler
Global Blood price target lowered to $40 from $45 at Piper Sandler
JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

08/05/21 Piper Sandler
Jounce Therapeutics price target lowered to $17 from $20 at Piper Sandler
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades J&J to Equal Weight amid limited mid-term newsflow
09/07/21 Morgan Stanley
Johnson & Johnson downgraded to Equal Weight from Overweight at Morgan Stanley
08/20/21 Morgan Stanley
J&J CEO change 'a surprise,' but not due to business issues, says Morgan Stanley
KRTX Karuna Therapeutics
$116.74 /

-4.93 (-4.05%)

08/30/21 Citi
Karuna Therapeutics initiated with a Buy at Citi
07/28/21
Fly Intel: Top five analyst initiations
07/28/21 Jefferies
Karuna Therapeutics initiated with a Buy at Jefferies
06/30/21 Citi
Karuna Therapeutics selloff brings buying opportunity, says Citi
KZR Kezar Life Sciences
$7.79 /

-0.03 (-0.38%)

07/20/21 JonesTrading
Kezar Life Sciences initiated with a Buy at JonesTrading
07/20/21 JonesTrading
Kezar Life Sciences initiated with a Buy at JonesTrading
LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

02/01/21
Fly Intel: Top five analyst initiations
02/01/21 SVB Leerink
SVB Leerink bullish on Lantheus, initiates with an Outperform
02/01/21 SVB Leerink
Lantheus initiated with an Outperform at SVB Leerink
12/29/20 Credit Suisse
Lantheus price target lowered to $14 from $16 at Credit Suisse
MDWD MediWound
$3.85 /

-0.07 (-1.79%)

06/29/21 Oppenheimer
MediWound NexoBrid CRL as expected, says Oppenheimer
03/02/21 Aegis
MediWound initiated with a Buy at Aegis
02/26/21 H.C. Wainwright
MediWound price target raised to $7 from $5.50 at H.C. Wainwright
10/19/20 BTIG
Vericel price target raised to $30 from $23 at BTIG
MDT Medtronic
$135.13 /

+0.57 (+0.42%)

08/27/21 Argus
Medtronic price target raised to $165 from $150 at Argus
08/25/21 Truist
Medtronic price target raised to $148 from $138 at Truist
08/25/21 Credit Suisse
Medtronic price target raised to $146 from $137 at Credit Suisse
08/25/21 Wells Fargo
Medtronic price target raised to $151 from $140 at Wells Fargo
PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

05/06/21 Roth Capital
Turning Point 'significantly undervalued' with catalysts ahead, says Roth
04/13/21 Roth Capital
Turning Point combo data show 'expansive pipeline potential,' says Roth Capital
04/06/21 Roth Capital
Turning Point price target raised to $175 from $170 at Roth Capital
03/02/21 Roth Capital
Turning Point has 'many value-driving catalysts' in 2021, says Roth Capital
SCI Service Corp.
$63.46 /

+0.825 (+1.32%)

05/10/21 Oppenheimer
Service Corp. price target raised to $59 from $54 at Oppenheimer
11/02/20 Credit Suisse
Service Corp. price target raised to $55 from $50 at Credit Suisse
SMFR Sema4 Holdings
$8.68 /

-0.55 (-5.96%)

SGMO Sangamo
$9.83 /

-0.19 (-1.90%)

05/03/21 RBC Capital
Sangamo initiated with an Outperform at RBC Capital
03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
RVNC Revance
$27.35 /

+0.06 (+0.22%)

05/11/21 Mizuho
Revance price target lowered to $36 from $37 at Mizuho
04/23/21 Mizuho
Revance price target raised to $37 from $33 at Mizuho
02/23/21 Mizuho
Revance price target raised to $33 from $30 at Mizuho
02/23/21 H.C. Wainwright
Revance price target raised to $35 from $33 at H.C. Wainwright
TFX Teleflex
$400.07 /

+1.03 (+0.26%)

09/07/21 Raymond James
Teleflex assumed with an Outperform at Raymond James
08/02/21 KeyBanc
Teleflex price target lowered to $439 from $448 at KeyBanc
07/19/21 SVB Leerink
Teleflex downgraded to Market Perform from Outperform at SVB Leerink
07/15/21 Piper Sandler
Teleflex, Itamar pullbacks on proposed rate cuts overdone, says Piper Sandler
TECH Bio-Techne
$507.70 /

-6.81 (-1.32%)

08/24/21 Argus
Bio-Techne price target raised to $540 from $490 at Argus
08/06/21 Baird
Bio-Techne price target raised to $522 from $430 at Baird
08/05/21 Benchmark
Bio-Techne price target raised to $540 from $480 at Benchmark
06/18/21 Argus
Bio-Techne price target raised to $490 from $440 at Argus
TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

08/17/21 Chardan
Taysha Gene Therapies price target lowered to $60 from $67.50 at Chardan
07/15/21 Needham
Taysha Gene Therapies initiated with a Buy at Needham
07/09/21 Chardan
Taysha Gene Therapies coverage transferred at Chardan
06/24/21 Truist
Truist starts Taysha Gene Therapies at Buy on potential de-risking events
TNDM TNDM
/

+

08/05/21 SVB Leerink
Tandem Diabetes price target raised to $123 from $102 at SVB Leerink
08/05/21 Craig-Hallum
Tandem Diabetes price target raised to $153 from $140 at Craig-Hallum
08/05/21 Wells Fargo
Tandem Diabetes price target raised to $121 from $112 at Wells Fargo
08/05/21 Oppenheimer
Tandem Diabetes price target raised to $140 from $135 at Oppenheimer
RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

08/12/21 SVB Leerink
Rapt Therapeutics initiated with an Outperform at SVB Leerink
07/12/21 Roth Capital
Roth adds more 'SMID-cap' names to second half top picks
06/23/21 JMP Securities
JMP raises Evelo Biosciences price target to $38 after Rapt reports data
06/23/21 H.C. Wainwright
Rapt Therapeutics price target raised to $56 from $29 at H.C. Wainwright
QURE uniQure
$34.68 /

-0.24 (-0.69%)

07/27/21 Chardan
uniQure price target lowered to $95 from $100 at Chardan
07/09/21 Chardan
uniQure coverage transferred at Chardan
06/23/21 Chardan
uniQure filing delay could yield better label for EtranaDez, says Chardan
06/16/21 Chardan
uniQure on track for 'powerful' Huntington's catalyst, says Chardan
NVTA Invitae
$31.17 /

-0.545 (-1.72%)

08/04/21 Benchmark
Invitae upgraded to Buy from Hold at Benchmark
06/21/21 Wells Fargo
Invitae price target raised to $35 from $30 at Wells Fargo
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

07/22/21 Deutsche Bank
Intuitive Surgical price target raised to $925 from $825 at Deutsche Bank
07/21/21 SVB Leerink
Intuitive Surgical price target raised to $975 from $930 at SVB Leerink
07/21/21 Evercore ISI
Intuitive Surgical price target raised to $980 from $825 at Evercore ISI
07/21/21 Wells Fargo
Intuitive Surgical price target raised to $1,060 from $916 at Wells Fargo
TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

TNDM TNDM
/

+

TFX Teleflex
$400.07 /

+1.03 (+0.26%)

SGMO Sangamo
$9.83 /

-0.19 (-1.90%)

SCI Service Corp.
$63.46 /

+0.825 (+1.32%)

RVNC Revance
$27.35 /

+0.06 (+0.22%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

KZR Kezar Life Sciences
$7.79 /

-0.03 (-0.38%)

KRTX Karuna Therapeutics
$116.74 /

-4.93 (-4.05%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

FLXN Flexion
$6.44 /

+0.165 (+2.63%)

FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

  • 16
    Jun
  • 10
    Mar
  • 02
    Mar
  • 22
    Jan
  • 06
    Jan
  • 08
    Dec
  • 11
    Nov
  • 27
    Oct
  • 24
    Sep
NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

FLXN Flexion
$6.44 /

+0.165 (+2.63%)

FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

SMFR Sema4 Holdings
$8.68 /

-0.55 (-5.96%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

Initiation
Karuna Therapeutics initiated with a Buy at Citi » 06:30
08/30/21
08/30
06:30
08/30/21
06:30
KRTX

Karuna Therapeutics

$115.00 /

+0.15 (+0.13%)

Citi analyst Neena…

Citi analyst Neena Bitritto-Garg initiated coverage of Karuna Therapeutics with a Buy rating and $152 price target. The analyst views the shares as "particularly attractive" following the recent weakness. Similarities between the Phase 2 and Phase 3 designs in schizophrenia and built-in placebo effect controls provide confidence that success is likely, Bitritto-Garg tells investors in a research note. The analyst also sees broader potential for KarXT in cognitive symptoms.

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$115.00 /

+0.15 (+0.13%)

KRTX Karuna Therapeutics
$115.00 /

+0.15 (+0.13%)

07/28/21
Fly Intel: Top five analyst initiations
07/28/21 Jefferies
Karuna Therapeutics initiated with a Buy at Jefferies
06/30/21 Citi
Karuna Therapeutics selloff brings buying opportunity, says Citi
06/30/21 Mizuho
Karuna selloff on Cerevel data 'appears overdone,' says Mizuho
KRTX Karuna Therapeutics
$115.00 /

+0.15 (+0.13%)

  • 02
    Mar
Over a month ago
Earnings
Karuna Therapeutics reports Q2 EPS ($1.17), consensus ($1.35) » 07:02
08/05/21
08/05
07:02
08/05/21
07:02
KRTX

Karuna Therapeutics

$108.03 /

-1.21 (-1.11%)

"Q2 was an exciting…

"Q2 was an exciting one for Karuna as we've made important progress in advancing our mid- and late-stage clinical trials studying our lead asset, KarXT, across multiple indications to drive innovation in the treatment of schizophrenia and dementia-related psychosis," said CEO Steve Paul. "All four Phase 3 trials in the EMERGENT program evaluating KarXT in schizophrenia are now enrolling, with completion of the first trial, EMERGENT-2, expected mid-2022. We also plan to evaluate KarXT in adults with schizophrenia who inadequately respond to atypical antipsychotics in a Phase 3 trial initiating later this year. We plan to advance KarXT into a Phase 2 clinical trial for the treatment of dementia-related psychosis in the first half of 2022 following encouraging results from our completed Phase 1b healthy elderly volunteer trial which suggest that potentially therapeutic doses of KarXT can be administered to elderly adults while maintaining a favorable tolerability profile. We are pleased with the breadth of milestones we've achieved in the first half of 2021, including significant growth across our organization, all of which we believe contribute to laying a strong foundation for the company as we seek to push the boundaries of neuroscience to transform mental illness."

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$108.03 /

-1.21 (-1.11%)

KRTX Karuna Therapeutics
$108.03 /

-1.21 (-1.11%)

07/28/21
Fly Intel: Top five analyst initiations
07/28/21 Jefferies
Karuna Therapeutics initiated with a Buy at Jefferies
06/30/21 Citi
Karuna Therapeutics selloff brings buying opportunity, says Citi
06/30/21 Mizuho
Karuna selloff on Cerevel data 'appears overdone,' says Mizuho
KRTX Karuna Therapeutics
$108.03 /

-1.21 (-1.11%)

  • 02
    Mar
Conference/Events
Karuna Therapeutics management to meet virtually with Mizuho » 04:55
08/02/21
08/02
04:55
08/02/21
04:55
KRTX

Karuna Therapeutics

$114.05 /

+0.47 (+0.41%)

Virtual Meeting to be…

Virtual Meeting to be held on August 2 hosted by Mizuho.

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$114.05 /

+0.47 (+0.41%)

KRTX Karuna Therapeutics
$114.05 /

+0.47 (+0.41%)

07/28/21
Fly Intel: Top five analyst initiations
07/28/21 Jefferies
Karuna Therapeutics initiated with a Buy at Jefferies
06/30/21 Citi
Karuna Therapeutics selloff brings buying opportunity, says Citi
06/30/21 Mizuho
Karuna selloff on Cerevel data 'appears overdone,' says Mizuho
KRTX Karuna Therapeutics
$114.05 /

+0.47 (+0.41%)

  • 02
    Mar
Conference/Events
Karuna Therapeutics management to meet virtually with Mizuho » 11:00
07/28/21
07/28
11:00
07/28/21
11:00
KRTX

Karuna Therapeutics

$113.43 /

+2.52 (+2.27%)

Virtual Meeting to be…

Virtual Meeting to be held on August 2 hosted by Mizuho.

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$113.43 /

+2.52 (+2.27%)

KRTX Karuna Therapeutics
$113.43 /

+2.52 (+2.27%)

07/28/21
Fly Intel: Top five analyst initiations
07/28/21 Jefferies
Karuna Therapeutics initiated with a Buy at Jefferies
06/30/21 Citi
Karuna Therapeutics selloff brings buying opportunity, says Citi
06/30/21 Mizuho
Karuna selloff on Cerevel data 'appears overdone,' says Mizuho
KRTX Karuna Therapeutics
$113.43 /

+2.52 (+2.27%)

  • 02
    Mar
Initiation
Fly Intel: Top five analyst initiations » 09:54
07/28/21
07/28
09:54
07/28/21
09:54
NYXH

Nyxoah

$33.02 /

+0.22 (+0.67%)

, SKLZ

Skillz

$14.27 /

+ (+0.00%)

, MSFT

Microsoft

$284.90 /

-1.99 (-0.69%)

, KRTX

Karuna Therapeutics

$115.00 /

+4.09 (+3.69%)

, ELA

Envela

$4.12 /

+0.09 (+2.23%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Nyxoah (NYXH) initiated with an Overweight at Cantor Fitzgerald and Piper Sandler. 2. Skillz (SKLZ) initiated with a Sector Perform at RBC Capital. 3. Microsoft (MSFT) assumed with an Outperform at RBC Capital. 4. Karuna Therapeutics (KRTX) initiated with a Buy at Jefferies. 5. Envela (ELA) initiated with a Buy at Lake Street. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
SKLZ Skillz
$14.27 /

+ (+0.00%)

MSFT Microsoft
$284.90 /

-1.99 (-0.69%)

KRTX Karuna Therapeutics
$115.00 /

+4.09 (+3.69%)

ELA Envela
$4.12 /

+0.09 (+2.23%)

NYXH Nyxoah
$33.02 /

+0.22 (+0.67%)

07/28/21 Cantor Fitzgerald
Nyxoah initiated with an Overweight at Cantor Fitzgerald
07/28/21 Cantor Fitzgerald
Nyxoah initiated with an Overweight at Cantor Fitzgerald
07/28/21 Piper Sandler
Nyxoah initiated with an Overweight at Piper Sandler
07/27/21
Fly Intel: Top five analyst initiations
SKLZ Skillz
$14.27 /

+ (+0.00%)

07/28/21 RBC Capital
Skillz initiated with a Sector Perform at RBC Capital
05/21/21 Citi
Skillz price target lowered to $23 from $27 at Citi
05/06/21 Wells Fargo
Skillz price target lowered to $18.50 from $28 at Wells Fargo
05/05/21 Canaccord
Skillz price target lowered to $30 from $33 at Canaccord
MSFT Microsoft
$284.90 /

-1.99 (-0.69%)

07/28/21 BMO Capital
Microsoft price target raised to $325 from $290 at BMO Capital
07/28/21 Wedbush
Wedbush bullish on Microsoft following 'robust' results, guidance
07/28/21 Credit Suisse
Microsoft price target raised to $320 from $300 at Credit Suisse
07/28/21 Stifel
Microsoft price target raised to $325 from $305 at Stifel
KRTX Karuna Therapeutics
$115.00 /

+4.09 (+3.69%)

07/28/21 Jefferies
Karuna Therapeutics initiated with a Buy at Jefferies
06/30/21 Citi
Karuna Therapeutics selloff brings buying opportunity, says Citi
06/30/21 Mizuho
Karuna selloff on Cerevel data 'appears overdone,' says Mizuho
06/23/21 William Blair
William Blair says Karuna DRP data show KarXT's 'pipeline in a drug potential'
ELA Envela
$4.12 /

+0.09 (+2.23%)

07/28/21 Lake Street
Envela initiated with a Buy at Lake Street
03/09/21
Fly Intel: Top five analyst initiations
03/09/21 B. Riley
B. Riley sees 100% upside in Envela, starts with Buy rating
03/09/21 B. Riley
Envela initiated with a Buy at B. Riley Securities
SKLZ Skillz
$14.27 /

+ (+0.00%)

MSFT Microsoft
$284.90 /

-1.99 (-0.69%)

KRTX Karuna Therapeutics
$115.00 /

+4.09 (+3.69%)

  • 19
    Mar
  • 02
    Mar
SKLZ Skillz
$14.27 /

+ (+0.00%)

MSFT Microsoft
$284.90 /

-1.99 (-0.69%)

SKLZ Skillz
$14.27 /

+ (+0.00%)

MSFT Microsoft
$284.90 /

-1.99 (-0.69%)

SKLZ Skillz
$14.27 /

+ (+0.00%)

MSFT Microsoft
$284.90 /

-1.99 (-0.69%)

Initiation
Karuna Therapeutics initiated with a Buy at Jefferies » 07:42
07/28/21
07/28
07:42
07/28/21
07:42
KRTX

Karuna Therapeutics

$111.05 /

-2.46 (-2.17%)

Jefferies analyst Chris…

Jefferies analyst Chris Howerton initiated coverage of Karuna Therapeutics with a Buy rating and $158 price target. Karuna's lead program, KarXT, is a combined drug product that is "likely to succeed" in the "huge market" of schizophrenia, where there have been no major mechanistic advances in decades, Howerton tells investors. While the opportunity for KarXT in schizophrenia is "unquestionably large," dementia-related psychosis, where the drug is also being studied, "could be double that," or a $3B-$4B opportunity, Howerton added.

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$111.05 /

-2.46 (-2.17%)

KRTX Karuna Therapeutics
$111.05 /

-2.46 (-2.17%)

06/30/21 Citi
Karuna Therapeutics selloff brings buying opportunity, says Citi
06/30/21 Mizuho
Karuna selloff on Cerevel data 'appears overdone,' says Mizuho
06/23/21 William Blair
William Blair says Karuna DRP data show KarXT's 'pipeline in a drug potential'
06/23/21 RBC Capital
Karuna Therapeutics price target raised to $173 from $164 at RBC Capital
KRTX Karuna Therapeutics
$111.05 /

-2.46 (-2.17%)

  • 02
    Mar
Recommendations
Karuna Therapeutics selloff brings buying opportunity, says Citi » 06:58
06/30/21
06/30
06:58
06/30/21
06:58
KRTX

Karuna Therapeutics

$111.16 /

-11.04 (-9.03%)

, CERE

Cerevel Therapeutics

$29.57 /

+17 (+135.24%)

Citi analyst Mohit Bansal…

Citi analyst Mohit Bansal views the selloff yesterday in shares of Karuna Therapeutics (KRTX) following competitor data from Cerevel Therapeutics (CERE) as a buying opportunity. The Karuna/Cerevel comparison is premature, as the Cerevel study was a single-center Phase 1/2 study, while the KarXT study was a large Phase 2 study, Bansal tells investors in a research note. Further, Cerevel does not appear better on psychosis and the market is big enough, "which could potentially help Karuna stand out," says the analyst. Bansal keeps a Buy rating on Karuna Therapeutics.

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$111.16 /

-11.04 (-9.03%)

CERE Cerevel Therapeutics
$29.57 /

+17 (+135.24%)

KRTX Karuna Therapeutics
$111.16 /

-11.04 (-9.03%)

06/30/21 Mizuho
Karuna selloff on Cerevel data 'appears overdone,' says Mizuho
06/23/21 William Blair
William Blair says Karuna DRP data show KarXT's 'pipeline in a drug potential'
06/23/21 RBC Capital
Karuna Therapeutics price target raised to $173 from $164 at RBC Capital
04/26/21 H.C. Wainwright
Karuna Therapeutics price target raised to $160 from $130 at H.C. Wainwright
CERE Cerevel Therapeutics
$29.57 /

+17 (+135.24%)

06/18/21 Morgan Stanley
Cerevel Therapeutics initiated with an Overweight at Morgan Stanley
12/10/20 Goldman Sachs
Cerevel Therapeutics initiated with a Buy at Goldman Sachs
11/23/20 Jefferies
Cerevel Therapeutics initiated with a Buy at Jefferies
KRTX Karuna Therapeutics
$111.16 /

-11.04 (-9.03%)

CERE Cerevel Therapeutics
$29.57 /

+17 (+135.24%)

  • 02
    Jul
  • 02
    Mar
CERE Cerevel Therapeutics
$29.57 /

+17 (+135.24%)

CERE Cerevel Therapeutics
$29.57 /

+17 (+135.24%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.